T. Rowe Price Investment Management, Inc. 13D/13G Filings for Avanos Medical, Inc. (AVNS)

T. Rowe Price Investment Management, Inc. 13D and 13G filings for Avanos Medical, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
1:28 pm
Purchase
2024-09-3013GAvanos Medical, Inc.
AVNS
T. Rowe Price Investment Management, Inc.2,367,045
5.200%
2,367,045increase
(New Position)
Filing